Global CEOs Set to Attend BioAsia 2024, Exploring New Age Technologies in Life Sciences and Pharma
The highly anticipated BioAsia 2024 conference is just around the corner, and this year’s event is expected to make waves in the life sciences and pharmaceutical industries. Taking place at the Hyderabad International Convention Centre (HICC) in Madhapur, Hyderabad, BioAsia 2024 will welcome renowned CEOs from around the world who will be attending the conference for the first time. With a focus on new age technologies, including data and artificial intelligence (AI), the event aims to delve into the challenges and opportunities presented in these sectors.
Organizers of the three-day forum have curated an exciting lineup of themes to be discussed at the event. These include ‘Transformative Innovation – R&D,’ ‘Patent Paradox: India’s Bid for Global R&D Dominance & IP Dilemmas,’ ‘Leading the Health-tech Revolution – The Next Normal,’ ‘India at the Frontier of Pharma Services,’ and ‘MedTech is the place to be,’ among others. The diversity of themes ensures a comprehensive exploration of various aspects within the life sciences, healthcare, biotech, and pharma sectors.
With more than 3000 delegates expected to participate from over 50 countries, BioAsia 2024 is set to be a truly global event. The government of Telangana, the organizing authority, aims to showcase investment and business opportunities in the healthcare, pharma, biotech, and life sciences sectors in the region. To ensure the successful execution of the event, Duddilla Sridhar Babu, the Minister for Information Technology, Industries & Commerce, recently conducted a comprehensive review meeting and provided guidance to the concerned authorities.
The government of Telangana considers BioAsia a critical instrument for the development of the Indian and global life science industries. Over the past two decades, the flagship event has played a pivotal role in redirecting attention to the advancements and challenges within the sector. Jayesh Ranjan, Principal Secretary, Department of Industries and Commerce, government of Telangana, highlighted the event’s unrivaled contribution to sparking rekindled interest from regulation, corporations, startups, and allied sectors.
BioAsia 2024 boasts an impressive lineup of more than 70 influential speakers, including global CEOs and industry leaders representing leading international life sciences and pharmaceutical companies. Among them are David Ricks, CEO of Eli Lilly and Company; Dr. Christopher Boerner, Incoming CEO of Bristol Myers Squibb; Geoff Martha, Chairman and CEO of Medtronic; and Prof. Gregg Semenza, Nobel Laureate & Professor at Johns Hopkins School of Medicine, among others. Keynote addresses will be delivered by industry stalwarts, including David Ricks.
The event will also host an exhibition, with over 200 companies showcasing their innovative and cutting-edge products. This provides a unique networking opportunity and a chance to witness the latest advancements in the life sciences and biotechnology sectors. Moreover, BioAsia 2024 promises to be an ideal platform for promising startups in the pharmaceutical, biotech, life sciences, health-tech, and med-tech sectors to present their inventive concepts to a global audience.
As the stage is set for the grand unveiling, countless influential leaders from around the world are preparing to converge in Hyderabad. BioAsia 2024 aims to bridge gaps in the healthcare industry and foster innovation in these critical sectors. With its impressive lineup of speakers and participants, the conference is expected to attract attention and provide valuable insights into the future of life sciences and pharmaceuticals.
BioAsia’s continued commitment to advancing the industry and its role in promoting groundbreaking research and development make it a key player in the global life sciences arena. As the event approaches, anticipation is rising, and participants eagerly await the knowledge exchange and innovation that BioAsia 2024 promises. With its global reach and visionary approach, the conference is poised to make a lasting impact on the future of life sciences and pharmaceuticals.
Reference:
[Global CEOs to Attend BioAsia 2024, Exploring New Age Technologies in Life Sciences and Pharma]
